MSI2 and colitis: Next, we used MSI2 knockout (MSI2-/-) transgenic and wild-type (MSI2+/+) mice to construct a colitis-associated colon cancer model by administering azoxymethane (AOM) intraperitoneally and feeding with 3% DSS for three cycles (Fig. 6D).